We cloned and sequenced the cDNAs for R-type pyruvate kinase (R-PK) from three homozygous PK patients. A point mutation (""ACG to AIG) identified in the R-PK cDNA of PK Nagasaki was identical with that previously identified in an unrelated family, PK Tokyo. The mutation has also been identified in the PK L gene of a Lebanese family, PK Beirut, by Neubauer et al (Blood 77:1871,1991) . These results suggest either that the point mutation is very old or that the same mutation occurs sporadically in the same hot spot in unrelated families. A point mutation, ' V A G to AAG, was detected in both PK Fukushima and PK Maebashi3his mutation YRUVATE KINASE (PK) is a key glycolytic enzyme P and has four isozymes in mammals.'.' The type-R
(R-PK) is specifically expressed in erythrocytes, and in other cells of hematopoietic lineage, type-M2 (M,-PK) is expressed. Congenital nonspherocytic hemolytic anemia (CNSHA) due to a deficiency of PK activity was first reported in 1961,' and it is now recognized as the most common cause among glycolytic enzyme defects.4~~ Over 300 cases of PK deficiency have been reported, and most PK variants are considered to be a result of a structural change in the PK L gene, which encodes both type L (L-PK) and R. 6 Recently, we cloned the cDNA for human R-PK, and identified a single amino acid substitution (Th1384 to Met) in the R-PK of the homozygous patients, PK T~k y o .~,~ This substitution caused PK instability, directly demonstrated by expression of the recombinant PK with the point mutation: More recently, Neubauer et al' reported point mutations found in the human L-PK gene of Turkish and Lebanese PK-deficient individuals. In this report, we describe two point mutations found in unrelated PK-deficient families associated with CNSHA and a polymorphic nucleotide change, which is commonly distributed in the Japanese population.
MATERIALS AND METHODS

Patients.
Case reports, laboratory data, and the enzymatic properties of PK Nagasaki, PK Fukushima, and PK Maebashi have been reported
Because of the consanguineous marriage of the parents, these patients are considered to be homozygous for the mutant PK alleles. Clinical histories and kinetic studies of compound heterozygotes of the PK variant, PK Osaka, PK Beppu, PK Niigata, and PK Nichinan have been des~ribed.l~-'~ Restriction endonucleases and modifying enzymes were purchased from Takara Shuzo (Japan) and New England Biolabs (Beverly, MA). Taq DNA polymerase (AmpliTaq) was obtained from Cetus (Norwalk, CT). Modifying T7 DNA polymerase (Sequenase; United Biochemicals, Cleveland, OH) was used for DNA sequencing. a "P dCTP and y 32P ATP were purchased from Amersham (UK). The computer software, DNASIS (Hitachi Software Engineering, Japan), was used for analysis of the hydrophobicity properties of the variant protein based on the theory of Hopp and Woods.I6
Oligonucleotides used for cDNA cloning have been described previously.' L10 (5'-GTCCTACAACTTTGA-CATCC-3') and L12 (5-TAGCTCCTCAAACAGCTGC-3') were used for amplifying the exon 9-10 region of the PK L gene. L21 (5'-GAAAGCrCCGTGGCCCTCCG-3') and L22 (5'-GTA-
Materials.
Oligonucleotides. causes a single amino acid substitution, from Gin'" to Lys, in R-PK. Consequently, the hydrophobicity properties near the mutated site are drastically changed. A silent mutation ("%AGG to CGG) was also identified in those variants. The screening of these three point mutations showed only the silent mutation in a normal individual as well as in individuals with PK variants. These results indicate that the multiplicity of the mutant PK allele is smaller than expected, and that the silent mutation is a polymorphic change commonly distributed in the Japanese population. cDNA synthesis, ampli@ation, and sequencing of R-type PK mRNA. Purification of reticulocyte RNA from patients, PK Nagasaki, PK Fukushima, and PK Maebashi, cDNA synthesis, and amplification of the R-PK cDNA were performed as described previously! Briefly, the R-PK cDNA were amplified with four sets of primers, and subcloned into pBluescript (Stratagene, La Jolla, CA). Whole coding and 55 bp 3' noncoding sequences were sequenced by the dideoxy method.
A S 0 hybridization for detecting point mutations in genomic DNA from other PK variants. To detect the mutations identified in PK Nagasaki, PK Fukushima, and PK Maebashi in the PK L gene of other PK variants, we used A S 0 hybridization technique. Because both '"'ACG to ATG and Iz1CAG to &4G mutations are located in exon 9 of human L-PK gene (our unpublished results, January 1990), we amplified a 330-bp genomic DNA fragment that flanked whole exon 9 sequences using primers L10 and L12 under conditions previously described.' To detect the '"'C to T mutation, either ASOWT or ASOPK primers' were used, and 1261C and 1261A were used for lZ6'C to A mutation. Hybridization was performed in 5X SSPE (1X SSPE is 0.18 mol/L NaCl, 10 mmol/L phosphate pH 7.4, 1 mmol/L EDTA), 5X Denhardt's solution, 0.1% sodium dodecyl sulfate (SDS), 100 p,g/mL denatured salmon sperm DNA, at 57°C for ASOWT, 54°C for ASOPK, 55°C for 1261C, and 52°C for 1261A. The final washing conditions were 60°C for ASOWT, 57°C for ASOPK, 58°C for 1261C, and 56°C for 1261A in 6X SSC 1348 KANNO ET AL (1X SSC is 0.15 mol/L NaCI, 0.015 mol/L sodium citrate, pH 7.0).
0.1% SDS.
Detection of the "2 to C silent mutation in the Japanese population. To test whether the silent mutation, '""A to C, is present in other PK variants and normal subjects, we amplified 0.5 +g of the genomic DNA from a normal subject and PK variants by polymerase chain reaction (PCR) with primers L21 and L22 under the conditions previously described." One fifth of the products were digested with BspHl (NEB) according to the manufacturer's recommended conditions and electrophoresed in a composite gel of 3% NuSieve agarose (FMC Bioproducts, Rockland, ME) and 1% HGT agarose (FMC Bioproducts).
RESULTS
Identijication of the same mutation as PK Tokyo in the R-PK cDNA of PK Nagasaki. Sequencing of the R-type PK cDNA from PK Nagasaki showed that the variant had the same point mutation as PK Tokyo, ""ASG to ATG. This mutation causes a single amino acid substitution at Thru" to Met, which causes thermal instability of the PK.8 This point mutation was also identical with that in the PK L gene of a Lebanese PK-deficient patient, PK Beirut, reported by Neubauer et a1.9
Single amino acid substitution, Gln"' to Lys, caused by a point mutation, l2''C to A, identijied in the R-type PK cDNA in both PK Fukushima and PK Maebashi. Sequencing of the R-PK cDNA from PK Fukushima demonstrated a point mutation, '&'CAG to AAG (Fig l) , which caused a single amino acid s u b s t i t~t i o~G 1 n~~' to Lys. Although the site was not located in the active site, which has been proposed from the tertiary structure deduced from cat muscle PK,I7 this substitution causes a diverse change of the net charge in the eighth a helix of the A domain of PK.I7 The hydrophobicity properties of the R-type PK near the mutated site are drastically changed by this substitution (Fig 2) . The R-PK cDNA of PK Maebashi also had the same point mutation. A silent point mutation, "%CC to CCC, was detected in the R-type PK cDNA of PK Fukushima and PK Maebashi. A point mutation, "' AGG to CGG, was also detected in the R-type PKcDNA ofboth PK-Fukushima and PK Maebashi. This mutation does not change an amino acid residue (Ser). We evaluated the existence of this nucleotide change in the genomic DNA from normal subjects and PK variants by amplifying exon 12 of the PK L gene, and by BspHI digestion of the products. Because the point mutation altered the recognition sequence of this restriction endonuclease, from TCGCGA to TCGCGC, the mutation was detected by the disappearance of the BspHI cutting site in the PCR products. Figure 3 shows the agarose electrophoresis of the BspHI digest of PCR samples. This mutation was found in the PK L gene of both PK-deficient patients and a normal individual, and 8 PK alleles of 18 have this mutation. Both PK Tokyo and PK Nagasaki, the variants with ""C to T mutation, are homozygous for adenine at no. 1705, and in contrast, both PK Fukushima and PK Maebashi, those with Iz6'C to A mutation, are homozygous for cytosine at the polymorphic base. Among four other compound heterozygous PK variants, PK Nichinan and PK Beppu are homozygous for ImA, and the others, PK Niigata and PK Osaka, are heterozygous for the nucleotide at 1705. A S 0 hybridization for screening the point mutations in other Japanese PK families. Because both lls'C to T and IZ6'C to A mutation were identified in unrelated families, we screened these mutations in other PKvariants, who showed slow-electrophoretic mobility or thermal instability in their enzymatic properties.'.'.'' All four PK variants examined are considered to be compound heterozygotes. AS0 hybridization demonstrated that PK Nagasaki was homozygous for the point mutation as well as PK Tokyo (Fig 4) , and that both PK Fukushima and PK Maebashi were homozygous for the 1261C to A mutation. Among other PK variants tested, none had these point mutations.
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Control
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From  Fig 3. Ethidium bromide staining of the agarose gel in which the BspHI-digested PCR products of exon 12 from the normal subject and the PK variants were electrophoresed. The PCR products are resistant t o the BspHl digest, when the "A t o C polymorphism is present. IftheBspHl site remains, the 144-bp products are digested into two fragments, 84 and 60 bp. M, molecular standard, pBR322 digested Mspl; N, normal control; 1, PK Fukushima; 2, PK Maebashi; 3, PK Tokyo; 4, PK Nagasaki; 5, PK Niigata; 6, PK Nichinan; 7, PK Osaka; 8, PK Beppu. We report here two point mutations in three homozygous PK variants, and a polymorphic nucleotide change found in the Japanese population. Thc PKvariants that wcre considered unique have proven to be identical from our present results; the point mutation found in PK Nagasaki is idcntical with those previously detected in another Japanese family with PK variant, PK Tokyo'." and a Lcbancsc PK variant, PK Beirut, reported by Neubauer et al." When the biochemical characters of these three variants wcre compared,U." the parameters such as thermal stability, electrophoretic mobility, optimum pH, ATP inhibition, and FDP (Fructose-l,6-diphosphate) activation were almost idcntical; however, thcre were some discrepancies in nucleotide specificity between the three variants and in the Michaelis constant for ADP and phosphoenolpyruvate between our data" and that of Neubauer et al." These discrepancies may be caused by the mutant enzymes being unstable during biochemical characterization. Similar discrepancies have been described in the biochemical and genetic analyses of the glucose-6-phosphate dchydrogenase deficiency, one of the major genetic defects which causes CNSHA.'' The fact that thc mutation has been found in three unrelated families of different races means either that this mutation occurred long before racial divergence between Lebanesc and Japanese, or that it occurred sporadically in the same hot spot in the human L-PK gene in unrelated families. We are inclined to favor the former explanation, bccause PK Tokyo and PK Nagasaki seem to be derived from a common evolutional origin judging from the fact that both of them are homozygous for the adenine at no. 1705 of the R-PK cDNA, which are polymorphic nucle- 
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PK Nagasaki; 5, PK Niigata; 6, PK Nichinan; 7, PK Osaka; 8, PK Beppu. AS0 probes used in the hybridization were: A, ASO-WT; B, ASO-PK; C, 1261C; D, 1261A.
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From otides in the Japanese population. A similar speculation can be applied to individuals with PK Fukushima and PK Maebashi, who are homozygous for cytosine at no. 1705. These results indicate that these mutations occurred in a common ancestor. Further information about DNA polymorphisms of the PK gene will provide insights into the origin of these PKvariants.
The point mutation found in PK Fukushima causes a single amino acid substitution, Gln4" to Lys. The hydrophobicity properties are drastically changed by this substitution (Fig 2) . As a result, stability of the patient's PK is severely impaired. It should be noted that both the mutation identified in PK Tokyo, ''"C to T, and this mutation reside in exon 9 of the human PK L gene. This observation suggests that the exon 9-encoded region may be functionally important for PK activity. The relationship between structure and function of PK will be further clarified by structural studies on PKvariants.
